Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Acute inflammatory demyelinating polyneuropathy

Known as: Polyneuropathies, Acute Inflammatory, Acute, Inflammatory Polyneuropathy, Acute Infectious Polyneuritis 
An acute inflammatory process affecting the peripheral nervous system and nerve roots. It results in demyelination. It is often caused by an acute… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2020
Highly Cited
2020
Importance The outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, is serious and has the potential to become an… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Review
2018
Review
2018
Background and Purpose— The purpose of these guidelines is to provide an up-to-date comprehensive set of recommendations for… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
2015
Highly Cited
2015
BACKGROUND In patients with acute ischemic stroke caused by a proximal intracranial arterial occlusion, intraarterial treatment… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
Review
2013
Review
2013
Background and Purpose— The authors present an overview of the current evidence and management recommendations for evaluation and… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
2009
Highly Cited
2009
BACKGROUND The direct oral thrombin inhibitor dabigatran has a predictable anticoagulant effect and may be an alternative therapy… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Highly Cited
2008
Highly Cited
2008
BACKGROUND Intravenous thrombolysis with alteplase is the only approved treatment for acute ischemic stroke, but its efficacy and… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 5
Highly Cited
2000
Highly Cited
2000
Multiple sclerosis (MS) is a disease with profound heterogeneity in clinical course, neuroradiological appearance of the lesions… Expand
Highly Cited
1999
Highly Cited
1999
CONTEXT Intravenous tissue-type plasminogen activator can be beneficial to some patients when given within 3 hours of stroke… Expand
Highly Cited
1995
Highly Cited
1995
OBJECTIVE To evaluate the efficacy and safety of intravenous thrombolysis using recombinant tissue plasminogen activator (rt-PA… Expand
Review
1993
Review
1993
Background and Purpose The etiology of ischemic stroke affects prognosis, outcome, and management. Trials of therapies for… Expand
  • table 1
  • table 2
  • table 3
  • table 4